STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance, Beginning at Dec. 31, 2022	$ 6	$ 492,665	$ (1,355)	$ (144,600)	$ 346,716
Balance, Beginning (in shares) at Dec. 31, 2022	63,257,376
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs	$ 1	52,549			52,550
Issuance of common stock, net of offering costs (in shares)	6,928,044
Exercise of stock options and vesting of restricted stock units		117			117
Exercise of stock options and vesting of restricted stock units (in shares)	172,663
Purchase of common stock under employee stock purchase plan		596			596
Purchase of common stock under employee stock purchase plan (in shares)	95,259
Stock-based compensation		17,560			17,560
Other comprehensive income			1,454		1,454
Net loss				(100,163)	(100,163)
Balance, Ending at Dec. 31, 2023	$ 7	563,487	99	(244,763)	$ 318,830
Balance, Ending (in shares) at Dec. 31, 2023	70,453,342				70,453,342
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs	$ 2	238,797			$ 238,799
Issuance of common stock, net of offering costs (in shares)	22,450,206
Exercise of stock options and vesting of restricted stock units		9,480			9,480
Exercise of stock options and vesting of restricted stock units (in shares)	1,787,832
Purchase of common stock under employee stock purchase plan		888			888
Purchase of common stock under employee stock purchase plan (in shares)	147,086
Stock-based compensation		24,711			24,711
Other comprehensive income			321		321
Net loss				(133,813)	(133,813)
Balance, Ending at Dec. 31, 2024	$ 9	$ 837,363	$ 420	$ (378,576)	$ 459,216
Balance, Ending (in shares) at Dec. 31, 2024	94,838,466				94,838,466